C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 7/01 (2006.01) A61K 31/70 (2006.01) A61K 39/21 (2006.01) A61K 39/295 (2006.01) C07K 14/155 (2006.01) C07K 14/16 (2006.01) C07K 14/33 (2006.01) C12N 15/863 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2110489
2110489 9222641 PCTABS00018 What is described is a recombinant poxvirus, such as vaccinia virus, canarypox virus and fowlpox virus, having enhanced safety and containing foreign DNA from an immunodeficiency virus, such as human immunodeficiency virus and simian immunodeficiency virus. What is also described is an immunogenic composition which induces an immunological response against immunodeficiency virus infections when administered to a host.
Cox William I.
Franchini Genoveffa
Gallo Robert
Paoletti Enzo
Tartaglia James
Connaught Technology Corporation
Smart & Biggar
The Government Of The United States Of America
Virogenetics Corporation
LandOfFree
Immunodeficiency virus recombinant poxvirus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunodeficiency virus recombinant poxvirus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunodeficiency virus recombinant poxvirus vaccine will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1643554